A bioinformatics analysis of The Cancer Genome Atlas revealed that MAPK4 upregulation is significantly correlated with decreased overall survival in patients with lung adenocarcinoma, bladder cancer, low-grade glioma, and thyroid carcinoma54. This evidence concerns the gene MAPK4 and lung adenocarcinoma.